Latest Breaking News On - Trisha roy - Page 7 : comparemela.com

U.S. starts national Medicare coverage policy review for Biogen s Aduhelm 07/12/2021 22:09 (Reuters) -The U.S. government on Monday started a review process for national Medicare coverage of Biogen Inc s Alzheimer s drug, Aduhelm, that was recently approved by the country s health regulator. The Centers for Medicare & Medicaid Services (CMS) expects to give a proposed decision within 6 months and a final decision within 9 months. (https://go.cms.gov/3hzMa6H) Aduhelm is priced at $56,000 per year, which could represent significant spending for the government s Medicare program for people aged 65 and older. Currently, coverage for the drug is determined at the local level by Medicare administrative contractors, who represent 12 jurisdictions across the country.

New yorkUnited statesShounak dasguptaTrisha royCaroline humerBiogen inc alzheimerCenters for medicare medicaid servicesBiogen incMedicaid servicesபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்ஷ்ௌுனாக் தாஸ்குப்தாதிரிஷா ராய்பயோஜென் இன்க் முதுமறதிமையங்கள் க்கு மருத்துவ மருத்துவ உதவி சேவைகள்பயோஜென் இன்க்